New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
The new Phase III study will test calderasib in a chemo-free regimen for G12C-mutated patients regardless of PD-L1 status.
In the child welfare system, the threshold at which a drug test is considered positive varies widely from one jurisdiction to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback